Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

678 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-10-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A hospitals manual method of patient monitoring will be implemented in an automated system and supported by an early patient deterioration detection for timely escalation. The purpose of this study is to assess if clinical outcomes of patients in Acute Care are significantly improved by such a system.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

vHDU Phase 5: Impact of an Ambulatory Monitoring System on Deterioration Detection and Clinical Outcomes

NCT05118477

Surgery Deterioration, Clinical

RECRUITING NA

Early Warning System for Clinical Deterioration on General Hospital Wards

NCT01280942

Escalation of Care Cardiopulmonary Arrest Respiratory Arrest +2 more

COMPLETED NA

The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III

NCT02973243

Cardiac Arrest Renal Failure Respiration Failure +2 more

COMPLETED

Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care

NCT02893462

Critical Illness

RECRUITING

Prediction of Patient Deterioration Using Machine Learning

NCT05045742

Infection Heart Failure Chronic Obstructive Pulmonary Disease +6 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to assess if the Philips IntelliVue Guardian Solution (IGS) with all its components can significantly improve clinical outcomes for deteriorating patients on a general medical ward prior and after referral to the hospitals' Acute Care Team (ACT). Further, to provide evidence that the Philips IGS assists to increase the efficiency of a hospital's Early Warning Scoring process (afferent and efferent arm of the escalation system).

The introduction of such an intelligent automated system offers a unique opportunity to address the breakdown in the chain of prevention by strengthening the reliability of calls-for-help to responders through a technical solution with the potential for a more timely escalation where appropriate.

In this study the hospital's Standard of Care protocol for the monitoring of vital signs (including timing, vital signs collected and escalation instructions) will be implemented in a commercially available intelligent automatic monitoring and notification system. No investigational procedures or devices are associated with this protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe Sepsis Cardiac Arrest Respiratory Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RRT calls prior to IGS use

Patients who triggered ACT/RRT calls prior to the installation of the IGS (Intellivue Guardian System)

No interventions assigned to this group

RRT calls during IGS use

Patients who triggered ACT/RRT calls after the installation of IGS. All patients on the study ward receive the same care in both groups. The only difference is the system used to collect vital signs and to inform the staff about patient deteriorations. In Group 2, the IGS (FDA approved and CE marked) is the vital signs collection and information system.

No interventions assigned to this group